Delivery Order #SPE2DR26FSZT7

Delivery Order for Insulin Supply under AmerisourceBergen Pharmaceutical Contract

This award is a delivery order contract issued to AmerisourceBergen Drug Corporation, a prominent pharmaceutical distributor, under an existing long-term indefinite delivery vehicle contract focused on pharmaceutical supplies. The contract entails the procurement of Insulin Glargine Max Solo U300 3ML, a crucial medication for diabetes management, supporting healthcare treatment efforts. The significance of this delivery order lies in its contribution to maintaining a reliable pharmaceutical supply chain, ensuring timely access to essential medicines for patient care. The scope of work includes the provision and delivery of the specified insulin product within a short performance period, reflecting responsive supply logistics. This delivery order operates under the umbrella of the overarching AmerisourceBergen Awarded Long-Term Pharmaceutical Supply Contract, highlighting continuity and consistency in pharmaceutical procurement. The award was competitively managed through the parent contract vehicle, demonstrating adherence to federal acquisition practices. The period of performance for this delivery order is brief but critical for addressing immediate pharmaceutical needs at the designated location in Conshohocken, Pennsylvania.

Description

4570837296!INSULIN GLARGINE MAX SOLO U300 3ML

View original record